Silence Therapeutics PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
70.07 M |
Public Float |
- |
Silence Therapeutics PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.26 |
Market Cap |
GBP54.89 M |
Shares Outstanding |
70.07 M |
Public Float |
27.98 M |
Address |
72 Hammersmith Road London Greater London W14 8TH United Kingdom |
Employees | - |
Website | http://silence-therapeutics.com |
Updated | 07/08/2019 |
Silence Therapeutics Plc engages in the development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. Its proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. |